BioDelivery Sciences International IncBioDelivery Sciences International Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This ESG score includes 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Responsible Production & Consumption' and 'Life on Land'. This page includes a Q&A table for BioDelivery Sciences International Inc. This webpage of BioDelivery Sciences International Inc was prepared by All Street Sevva using advanced AI.

BioDelivery Sciences International Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 3.2, social score of 0.0 and governance score of 1.3.

SDG Transparency Score for BioDelivery Sciences International Inc 

1.6

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for BioDelivery Sciences International Inc 
3.2

Environmental

0.0

Social

1.3

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
2304Ste Promotion Pharmaceutique du Maghreb SA
1.7
Low
2304Reflect Scientific Inc
1.7
Low
2329BioDelivery Sciences International Inc
1.6
Low
2329Amicogen Inc
1.6
Low
2329Chongqing Pharscin Pharmaceutical Co Ltd
1.6
Low
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does BioDelivery Sciences International Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc report the average age of the workforce?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc offer flexible work?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc conduct supply chain audits?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose water use targets?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did BioDelivery Sciences International Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has BioDelivery Sciences International Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is BioDelivery Sciences International Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose its waste policy?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose energy use targets?

LockedSign up for free to unlock

Does BioDelivery Sciences International Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does BioDelivery Sciences International Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for BioDelivery Sciences International Inc
These potential risks are based on the size, segment and geographies of the company.

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.

Sorry!

Failed to process!